GlassScriptPhysician profile
Victoria A Rademaker
NPI 1356396352
$10,412.43
in general payments reported to CMS, 2019-2025
48 companies · $2,065 in 2025
The $2,065 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,622 · 2022: $2,177 · 2023: $2,517 · 2024: $2,031 · 2025: $2,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,576 · Long Term Medical Supply Or Device Loan: $37.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,576.27 |
| Long Term Medical Supply Or Device Loan | $37.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,802.21 | 2021-2025 | |
| Boston Scientific Corporation | $1,088.55 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Collegium Pharmaceutical, INC. | $727.23 | 2021-2025 | Xtampza |
| Pfizer INC. | $712.88 | 2021-2025 | |
| Ibsa Pharma INC. | $534.77 | 2021-2025 | Tirosint, Tirosint, Licart |
| Abbott Laboratories | $465.57 | 2023-2025 | Proclaim |
| Nevro Corp. | $437.99 | 2021-2024 | Senza |
| Almatica Pharma LLC | $386.91 | 2021-2023 | Gralise |
| Averitas Pharma INC. | $364.42 | 2023-2025 | Qutenza |
| Medtronic, INC. | $347.45 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Amgen INC. | $325.22 | 2021-2024 | Evenity, Prolia |
| Grt US Holding, INC. | $243.17 | 2021-2022 | |
| Allergan, INC. | $237.86 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $192.63 | 2022 | |
| Saluda Medical Americas, INC. | $189.21 | 2024-2025 | Evoke |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Rademaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.